Literature DB >> 22378820

Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.

Liliya M Yamaleyeva1, Shea Gilliam-Davis, Igor Almeida, K Bridget Brosnihan, Sarah H Lindsey, Mark C Chappell.   

Abstract

We examined the impact of early diabetes on the circulating and kidney renin-angiotensin system (RAS) in male and female mRen2.Lewis (mRen2) hypertensive rats. Diabetes (DB) was induced by streptozotocin (STZ; 65 mg/kg) at 11 wk of age for 4 wk without insulin replacement. Systolic blood pressures were not increased in DB males or females compared with controls (CON). Circulating angiotensin-converting enzyme 2 (ACE2) increased ninefold (P < 0.05) in DB females and threefold (P < 0.05) in DB males, but circulating ACE and ANG II were higher in the DB groups. Serum C-reactive protein was elevated in DB females but not DB males, and the vascular responses to acetylcholine and estradiol were attenuated in the DB females. Proteinuria, albuminuria, and angiotensinogen excretion increased to a similar extent in both DB females and males. Glomerular VEGF expression also increased to a similar extent in both DB groups. Renal inflammation (CD68(+)cells) increased only in DB females although males exhibited greater inflammation that was not different with DB. Cortical ACE2 did not change in DB females but was reduced (30%) in DB males. Renal neprilysin activity (>75%, P < 0.05) was markedly reduced in the DB females to that in the DB and CON males. ACE activity was significantly lower in both female (75%, P < 0.05) and male (50%; P < 0.05) DB groups, while cortical ANG II and Ang-(1-7) levels were unchanged. In conclusion, female mRen2 rats are not protected from vascular damage, renal inflammation, and kidney injury in early STZ-induced diabetes despite a marked increase in circulating ACE2 and significantly reduced ACE within the kidney.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378820      PMCID: PMC3378178          DOI: 10.1152/ajprenal.00656.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  65 in total

1.  Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.

Authors:  JiuChang Zhong; Ratnadeep Basu; Danny Guo; Fung L Chow; Simon Byrns; Manfred Schuster; Hans Loibner; Xiu-hua Wang; Josef M Penninger; Zamaneh Kassiri; Gavin Y Oudit
Journal:  Circulation       Date:  2010-08-02       Impact factor: 29.690

2.  Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.

Authors:  Atsushi Shiota; Koichi Yamamoto; Mitsuru Ohishi; Yuji Tatara; Miyuki Ohnishi; Yoshihiro Maekawa; Yoshihiro Iwamoto; Masao Takeda; Hiromi Rakugi
Journal:  Hypertens Res       Date:  2010-02-26       Impact factor: 3.872

3.  The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.

Authors:  Vinayak Shenoy; Anderson J Ferreira; Yanfei Qi; Rodrigo A Fraga-Silva; Carlos Díez-Freire; Autumn Dooies; Joo Yun Jun; Srinivas Sriramula; Nithya Mariappan; Dorna Pourang; Changaram S Venugopal; Joseph Francis; Timothy Reudelhuber; Robson A Santos; Jawaharlal M Patel; Mohan K Raizada; Michael J Katovich
Journal:  Am J Respir Crit Care Med       Date:  2010-06-25       Impact factor: 21.405

4.  Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain.

Authors:  Jonathan A Cohen; Sarah H Lindsey; Nancy T Pirro; K Bridget Brosnihan; Patricia E Gallagher; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

5.  Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron.

Authors:  Marcus Pohl; Henriette Kaminski; Hayo Castrop; Michael Bader; Nina Himmerkus; Markus Bleich; Sebastian Bachmann; Franziska Theilig
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

6.  How increased VEGF induces glomerular hyperpermeability: a potential signaling pathway of Rac1 activation.

Authors:  Hui Peng; Cheng Wang; Zeng-chun Ye; Yan-ru Chen; Jun Zhang; Zhu-jiang Chen; Xue-qing Yu; Tan-qi Lou
Journal:  Acta Diabetol       Date:  2009-04-29       Impact factor: 4.280

7.  Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo.

Authors:  Travis W Hein; Uma Singh; Jeannette Vasquez-Vivar; Sridevi Devaraj; Lih Kuo; Ishwarlal Jialal
Journal:  Atherosclerosis       Date:  2009-02-12       Impact factor: 5.162

8.  Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats.

Authors:  Sarah Hoffmann Lindsey; Jonathan A Cohen; K Bridget Brosnihan; Patricia E Gallagher; Mark C Chappell
Journal:  Endocrinology       Date:  2009-04-16       Impact factor: 4.736

Review 9.  Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.

Authors:  Anderson J Ferreira; Robson A S Santos; Chastity N Bradford; Adam P Mecca; Colin Sumners; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

10.  Human recombinant ACE2 reduces the progression of diabetic nephropathy.

Authors:  Gavin Y Oudit; George C Liu; Jiuchang Zhong; Ratnadeep Basu; Fung L Chow; Joyce Zhou; Hans Loibner; Evelyne Janzek; Manfred Schuster; Josef M Penninger; Andrew M Herzenberg; Zamaneh Kassiri; James W Scholey
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more
  40 in total

1.  Of diabetic mice and ACE2: a new biomarker of renal disease?

Authors:  Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

Review 2.  Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data.

Authors:  Andrew M South; Hossam A Shaltout; Lisa K Washburn; Alexa S Hendricks; Debra I Diz; Mark C Chappell
Journal:  Clin Sci (Lond)       Date:  2019-01-08       Impact factor: 6.124

3.  Antenatal corticosteroids and the renin-angiotensin-aldosterone system in adolescents born preterm.

Authors:  Andrew M South; Patricia A Nixon; Mark C Chappell; Debra I Diz; Gregory B Russell; Beverly M Snively; Hossam A Shaltout; James C Rose; T Michael O'Shea; Lisa K Washburn
Journal:  Pediatr Res       Date:  2016-09-16       Impact factor: 3.756

4.  Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice.

Authors:  Esam S B Salem; Nadja Grobe; Khalid M Elased
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-22

5.  Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.

Authors:  Jan Wysocki; Minghao Ye; Ahmed M Khattab; Agnes Fogo; Aline Martin; Nicolae Valentin David; Yashpal Kanwar; Mark Osborn; Daniel Batlle
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

6.  Stable Isotope Labeling with Amino Acids (SILAC)-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease.

Authors:  Sergi Clotet; Maria Jose Soler; Marta Riera; Julio Pascual; Fei Fang; Joyce Zhou; Ihor Batruch; Stella K Vasiliou; Apostolos Dimitromanolakis; Clara Barrios; Eleftherios P Diamandis; James W Scholey; Ana Konvalinka
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

Review 7.  Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

Authors:  Mark C Chappell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

8.  Photoacoustic imaging for in vivo quantification of placental oxygenation in mice.

Authors:  Liliya M Yamaleyeva; Yao Sun; Tiffaney Bledsoe; Asia Hoke; Susan B Gurley; K Bridget Brosnihan
Journal:  FASEB J       Date:  2017-08-21       Impact factor: 5.191

9.  Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2.

Authors:  Hong Ji; Aline M A de Souza; Bilkish Bajaj; Wei Zheng; Xie Wu; Robert C Speth; Kathryn Sandberg
Journal:  Hypertension       Date:  2020-06-22       Impact factor: 10.190

Review 10.  ACE2 alterations in kidney disease.

Authors:  María José Soler; Jan Wysocki; Daniel Batlle
Journal:  Nephrol Dial Transplant       Date:  2013-08-16       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.